Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q1 FY27 results · Apr–Jun 2026
Dr. Lal Path Labs reported revenue from operations of ₹797.70 crore (up 19.1% from Q1 FY26) and net profit of ₹170.50 crore (up 27.2% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 797.70 | 669.80 | +19.1% | 702.70 | +13.5% |
| Other income | 31.90 | 28.10 | +13.5% | 24.00 | +32.9% |
| Total income | 829.60 | 697.90 | +18.9% | 726.70 | +14.2% |
| Profit before tax | 228.70 | 181.10 | +26.3% | 160.10 | +42.8% |
| Net profit for the period | 170.50 | 134.00 | +27.2% | 132.20 | +29.0% |
| Attributable to shareholders of the company | 169.50 | 132.40 | +28.0% | 131.30 | +29.1% |
| EPS, basic (₹) | 10.15 | 15.88 | not comparable | 7.86 | +29.1% |
| Net margin (%) | 21.4 | 20.0 | 18.8 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 764.40 | 640.70 | +19.3% | 675.20 | +13.2% |
| Other income | 29.90 | 26.30 | +13.7% | 37.00 | −19.2% |
| Total income | 794.30 | 667.00 | +19.1% | 712.20 | +11.5% |
| Profit before tax | 222.30 | 172.40 | +28.9% | 169.90 | +30.8% |
| Net profit for the period | 165.90 | 129.30 | +28.3% | 141.10 | +17.6% |
| EPS, basic (₹) | 9.94 | 15.51 | not comparable | 8.45 | +17.6% |
| Net margin (%) | 21.7 | 20.2 | 20.9 |
Consolidated
- Filed with BSE
- 24 Jul 2026, 17:57 IST
- Board meeting
- 24 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 Jul 2026, 17:57 IST
- Board meeting
- 24 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE